Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Scleroderma, Circumscribed clinical trials
1 of 2 indexed Scleroderma, Circumscribed trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Scleroderma, Circumscribed: 2 US clinical trials tracked, 1 recruiting.
Scleroderma, Circumscribed is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), running 1 of these trials.
Enrollment posture brief
Registry condition scleroderma-circumscribed
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Scleroderma, Circumscribed lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Scleroderma, Circumscribed on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Scleroderma, Circumscribed is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
University of Texas Southwestern Medical Center
NCT01808937
Study of Silicone-Associated Connective Tissue Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00001330
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Scleroderma, Circumscribed records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Scleroderma, Circumscribed trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Scleroderma, Circumscribed page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Scleroderma, Circumscribed trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) sponsors the most Scleroderma, Circumscribed trials on record, review their full trial history before evaluating a specific study. See National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Scleroderma, Circumscribed condition card totals 2 registered trials; most-linked intervention Morphea; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.